|
|
Pathogenic bacteria characteristics and Clinical significance of immunoglobulin, CRP, WBC and PCT in children with refractory pneumonia |
LIAO Zhaomei1, CAI Siming1, CHEN Jianbiao1, LV Hualong1, LEI Zhixian2 |
1. Department of Pediatrics, the Second Affiliated Hospital of Hainan Medical College, Haikou 570100, China;
2. Department of Pediatrics, children’s Hospital Affiliated to Hainan Medical College, Haikou 570100, China |
|
|
Abstract Objective To investigate the etiological characteristics of infection and the expression significance of immunoglobulin, C-reactive protein (CRP), white blood cell count (WBC) and procalcitonin (PCT) in children with refractory pneumonia (RMPP). Methods The clinical data of 213 children with RMPP and 87 children with general pneumonia (GMPP) admitted from January 2019 to March 2021 were retrospectively analyzed. Peripheral blood of two groups of children was collected to detect the levels of immunoglobulin, CRP, WBC, and PCT, bronchoalveolar lavage fluid (BALF) of RMPP children was collected for pathogen culture and drug sensitivity test. The receiver operating characteristic (ROC) curve was used to analyze the value of immunoglobulin, CRP, WBC, and PCT in the differential diagnosis of RMPP. Results A total of 158 strains of pathogens were detected in 13 children with RMPP, including 98 strains of Gram-negative bacteria and 60 strains of Gram-positive bacteria. The Gram-negative bacteria were mainly Klebsiella pneumoniae (29 strains), while the Gram-positive bacteria were mainly Streptococcus pneumoniae (31 strains) and Staphylococcus aureus (24 strains). The results showed that Klebsiella pneumoniae was sensitive to imipenem, ertapenem, piperacillin/tazobactam, tobramycin and amikacin. Streptococcus pneumoniae was sensitive to ceftriaxone, cefotaxime, meropenem, ertabenem, vancomycin, Linezolid, chloramphenicol, moxifloxacin, levofloxacin, while Staphylococcus aureus was sensitive to gentamicin, vancomycin, quinuprtin/Dafoputine, linezolid, tegacycline, moxifloxacin, and rifampicin. There was no difference in the levels of IgA and WBC between the two groups; The levels of IgG, IgM, CRP, and PCT in the RMPP group were higher than those in the GMPP group. The ROC curve shows that IgG, IgM, CRP, and PCT have a certain differential diagnosis value for RMPP (AUC=0.770, 0.778, 0.824, 0.806, P<0.001), and the combination of the four (AUC=0.902, P<0.001) has a differential diagnosis value Higher. Conclusion The pathogenic bacterias of children with RMPP are mainly Klebsiella pneumoniae, Streptococcus pneumoniae and Staphylococcus aureus. The above pathogenic bacterias should be covered during empirical treatment, and the pathogen should be detected as soon as possible. If the curative effect is not good, drug resistance should be considered . And promptly give targeted treatment based on the results of drug sensitivity. The IgG, IgM, CRP and PCT level apparently higher than GMPP group, and RMPP will not have a significant impact on WBC. Combined detection of IgG, IgM, CRP, and PCT can be used for the differential diagnosis of RMPP.
|
Received: 23 June 2022
|
|
|
|
|
[1] 陈华, 方磊, 周焕荣. 难治性支原体肺炎患儿铁蛋白水平及意义分析[J]. 中国妇幼健康研究, 2018, 29(11): 147-149.
[2] Gong H, Sun B, Chen Y, et al.The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia: A meta-analysis[J]. Medicine, 2021, 100(11): e24894.
[3] 黄燕. 支气管肺泡灌洗在肺炎支原体肺炎诊疗中的优势[J]. 医学与哲学, 2018, 39(2): 16-18.
[4] 席少婷. 儿童难治性肺炎支原体肺炎诊治进展[J]. 国际儿科学杂志, 2020, 47(6): 384-388.
[5] 国家卫生健康委员会人才交流服务中心儿科呼吸内镜诊疗技术项目专家组, 中国医师协会儿科医师分会内镜专业委员会, 中国医师协会内镜医师分会儿科呼吸内镜专业委员会, 等. 中国儿童难治性肺炎呼吸内镜介入诊疗专家共识[J]. 中国实用儿科杂志, 2019, 34(6): 449-457.
[6] 胡亚美, 江载芳. 诸福棠实用儿科学 (第八版) [M]. 北京: 人民卫生出版社, 2012.
[7] 张巧. 儿童难治性肺炎支原体肺炎发病机制及治疗研究进展[J]. 儿科药学杂志, 2019, 25(6): 65-67.
[8] 李庆玲, 陈正荣, 孙慧明, 等. 特征性临床表现结合BALF多病原检测对儿童难治性肺炎的诊断价值[J]. 江苏医药, 2019, 45(4): 59-64.
[9] 陈金妮, 李大伟, 林秋玉, 等. 难治性肺炎患儿感染病原学及HMGB1、TLR2、 TLR4表达[J]. 中华医院感染学杂志, 2020, 30(18): 2847-2850.
[10] Zhang XX, Chen ZR, Gu WJ, et al.Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia[J]. Epidemiol Infect, 2018, 146(11): 1384-1388.
[11] 曾利恒, 翁育清, 张毅, 等. 难治性肺炎患者病原菌分布及其耐药性分析[J]. 实用心脑肺血管病杂志, 2017, 25(2): 87-89.
[12] 常春霞. 难治性肺炎支原体肺炎患儿实验室指标及临床特点分析[J]. 中国妇幼保健, 2019, 34(5): 1086-1089.
[13] 涂金伟, 汪东海, 代继宏. 糖皮质激素辅助治疗难治性肺炎支原体肺炎的Meta分析[J]. 儿科药学杂志, 2018, 24(12): 5-9. |
|
|
|